Abiopharma

Clinical trial NCT07346495: completion date: 2027-01-01 → 2026-08-01.

Clinical trial NCT06637371 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-07 → 2027-04-10 3. primary completion date: 2027-06-07 → 2027-04-10 4. enrollment: 124 → 21 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07214844 updates: 1. start date: 2026-04-01 → 2026-04-16 2. completion date: 2027-05-01 → 2028-05-01 3. primary completion date: 2027-05-01 → 2028-05-01

Prosafe SE: Annual report 2025 in ESEF format

Beeline Uzbekistan and DataVolt Partner to Advance Central Asia’s Digital Infrastructure

DOGFISH HEAD DROPS THE “SECRET STASH COOLER” BECAUSE SOME COCKTAILS ARE TOO GOOD TO SHARE

Linkers Industries Limited Announces Entry into a Material Definitive Agreement

WesBanco, Inc. to Join S&P SmallCap 600 Index

FTHM Stock Alert: Halper Sadeh LLC is Investigating Whether Fathom Holdings Inc. is Obtaining a Fair Price for its Shareholders

ALOT Stock Alert: Halper Sadeh LLC is Investigating Whether AstroNova, Inc. is Obtaining a Fair Price for its Shareholders